Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...

In patients with heart failure with improved ejection fraction (EF), pharmacological therapy is rarely withdrawn, according ...

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

Discover the life-extending approaches to managing heart failure through medication adherence, lifestyle modifications, and ...

are still at higher risk of heart-related death or hospitalization if they stop taking heart failure medications. This is according to a new study from Karolinska Institutet published in the ...

Researchers at Columbia Universityfound that while both drugs effectively lower blood pressure and help prevent heart attacks, strokes, and heart failure, chlorthalidone comes with higher risks of ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

However, stopping beta-blocker medication was only associated with a higher risk in patients whose heart function had only moderately improved. “Our results show that heart failure medications ...